Helius Medical Technologies Inc Class A (HSDT) - Total Liabilities

Latest as of September 2025: $628.31 Million USD

Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has total liabilities worth $628.31 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Helius Medical Technologies Inc Class A to track the company's year-over-year net asset growth rate.

Helius Medical Technologies Inc Class A - Total Liabilities Trend (2013–2024)

This chart illustrates how Helius Medical Technologies Inc Class A's total liabilities have evolved over time, based on quarterly financial data. See HSDT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Helius Medical Technologies Inc Class A Competitors by Total Liabilities

The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their total liabilities.

Company Country Total Liabilities
Coeptis Therapeutics Inc
NASDAQ:COEP
USA $3.26 Million
Nano X Imaging Ltd
NASDAQ:NNOX
USA $19.46 Million
Engenco Ltd
AU:EGN
Australia AU$94.56 Million
Marchex Inc
NASDAQ:MCHX
USA $9.60 Million
OPAL Fuels Inc
NASDAQ:OPAL
USA $433.95 Million
Loulis Mills S.A.
AT:KYLO
Greece €125.32 Million
Thorney Opportunities Ltd
AU:TOP
Australia AU$24.49 Million
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩22.80 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Helius Medical Technologies Inc Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Helius Medical Technologies Inc Class A worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 40.03 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -4.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Helius Medical Technologies Inc Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Helius Medical Technologies Inc Class A (2013–2024)

The table below shows the annual total liabilities of Helius Medical Technologies Inc Class A from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 $2.48 Million -53.52%
2023-12-31 $5.34 Million -41.53%
2022-12-31 $9.14 Million +221.01%
2021-12-31 $2.85 Million +6.35%
2020-12-31 $2.68 Million -40.69%
2019-12-31 $4.51 Million -74.90%
2018-12-31 $17.97 Million +25.69%
2017-12-31 $14.30 Million +252.46%
2016-12-31 $4.06 Million 0.00%
2015-12-31 $4.06 Million +45.97%
2014-12-31 $2.78 Million +375.94%
2013-12-31 $583.95K --

About Helius Medical Technologies Inc Class A

NASDAQ:HSDT USA Asset Management
Market Cap
$68.15 Million
Market Cap Rank
#20618 Global
#4610 in USA
Share Price
$1.65
Change (1 day)
-2.94%
52-Week Range
$1.27 - $24.13
All Time High
$34851.25
About

Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.